David Bearman, MD Speaks to Medical Marijuana 411 on the Medicinal Benefits of Cannabis
There are a group of researchers around the world, that are very interested in the endocannabinoid system, interested in how that works, how it functions. Elger is one of those people. He and another PHD named Nichol wrote an article that appeared in Scientific America which I believe is entitled The Brains on Marijuana. We have discovered, we meaning scientists not me, at least two endocannabinoids, two different 21 carbon molecules that have receptor sites that can be stimulated by Cannabis. And Cannabis of course, has 66, at least 66 cannabinoids and those are 21 carbon molecules that may have different side chain and every time you have a different side chain you have a different substance. The endocannabinoid system was first characterized by Dr. Raphael Mechoulam who is an Israeli scientist. He isolated THC in 1964. He really is the grand ole man in terms of both research and clinical application of tincture of cannabis. In Israel they use Cannabis for treating PTSD, and has been used elsewhere, in Croatia its used to treat PTSD (Post Traumatic Stress Disorder). He also developed a synthetic molecule, Dextro Cannabinal, which he tested to see if it had neuron sparing effects. There has been a lot of anecdotal evidence that Cannabis is useful in retarding the progress of Multiple Sclerosis and Parkinson’s Disease. What Mechoulam was looking at was whether or not this Dextro Cannabinol would diminish brain damage from strokes or traumatic brain injury. And while the …
Related posts: